| 000 | 05592nam a22004815i 4500 | ||
|---|---|---|---|
| 001 | 978-3-211-73574-9 | ||
| 003 | DE-He213 | ||
| 005 | 20161121230739.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100301s2007 au | s |||| 0|eng d | ||
| 020 |
_a9783211735749 _9978-3-211-73574-9 |
||
| 024 | 7 |
_a10.1007/978-3-211-73574-9 _2doi |
|
| 050 | 4 | _aRC346-429.2 | |
| 072 | 7 |
_aMJN _2bicssc |
|
| 072 | 7 |
_aMED056000 _2bisacsh |
|
| 082 | 0 | 4 |
_a616.8 _223 |
| 245 | 1 | 0 |
_aNeuropsychiatric Disorders An Integrative Approach _h[electronic resource] / _cedited by M. Gerlach, Jürgen Deckert, K. Double, E. Koutsilieri. |
| 264 | 1 |
_aVienna : _bSpringer Vienna, _c2007. |
|
| 300 |
_aIX, 341 p. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aJournal of Neural Transmission. Supplementa ; _v72 |
|
| 505 | 0 | _aThe meeting of minds and times with Peter Riederer: an appreciation -- Succi nervorum: a brief history of neurochemistry -- Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y -- Endogenous oxidized indoles share inhibitory potency against [3H]isatin binding in rat brain -- Lipid content determines aggregation of neuromelanin granules in vitro -- Hydrogen peroxide is a true first messenger -- The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders -- Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis -- Luteolin protects rat PC 12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keapl-Nrf2-ARE pathway -- Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals -- Animal models in neurodegenerative diseases -- Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study -- Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture -- Biochemistry of postmortem brains in Parkinson’s disease: historical overview and future prospects -- Neuroprotection by propargylamines in Parkinson’s disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers -- Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson’s disease -- Low dose methylphenidate improves freezing in advanced Parkinson’s disease during off-state -- The long-term effects of the neurotoxin l-trichloromethyl-1,2,3,4-tetrahydro-?-carboline (TaClo) on cognitive performance in rats -- Observations on the cortical silent period in Parkinson’s disease -- CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity -- Pharmacokinetic studies of (—)-deprenyl and some of its metabolites in mouse -- Serum lipoprotein profile and APOE genotype in Alzheimer’s disease -- VITA study: white matter hyperintensities of vascular and degenerative origin in the elderly -- ?-Lipoic acid as a new treatment option for Alzheimer’s disease — a 48 months follow-up analysis -- Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein -- Long-term tetrahydroaminoacridine treatment and quantitative EEG in Alzheimer’s disease -- Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer’s disease -- Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach -- Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer’s disease and diabetes mellitus -- Improving linear modeling of cognitive decline in patients with mild cognitive impairment: comparison of two methods -- Interaction of attention and graphomotor functions in children with attention deficit hyperactivity disorder -- Therapeutic drug monitoring of antidepressants — clinical aspects -- The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view -- Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia -- Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice -- FZD3 is not a risk gene for schizophrenia: a case-control study in a Caucasian sample -- Impaired cortical inhibition in adult ADHD patients: a study with transcranial magnetic stimulation* -- Association of Parkinson’s disease with symptoms of attention deficit hyperactivity disorder in childhood -- Biostatistical analysis of gene microarrays reveals diverse expression clusters between macaque subspecies in brain SIV infection -- Kynurenines, redox disturbances and neurodegeneration in multiple sclerosis -- Neural stem cell transplantation in a model of fetal alcohol effects. | |
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aNeurology. | |
| 650 | 0 | _aClinical psychology. | |
| 650 | 1 | 4 | _aMedicine & Public Health. |
| 650 | 2 | 4 | _aNeurology. |
| 650 | 2 | 4 | _aClinical Psychology. |
| 700 | 1 |
_aGerlach, M. _eeditor. |
|
| 700 | 1 |
_aDeckert, Jürgen. _eeditor. |
|
| 700 | 1 |
_aDouble, K. _eeditor. |
|
| 700 | 1 |
_aKoutsilieri, E. _eeditor. |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783211735732 |
| 830 | 0 |
_aJournal of Neural Transmission. Supplementa ; _v72 |
|
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-3-211-73574-9 |
| 912 | _aZDB-2-SME | ||
| 950 | _aMedicine (Springer-11650) | ||
| 999 |
_c503389 _d503389 |
||